Amine Pharma (Japan)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Biochemistry, Genetics and Molecular Biology 13.3×
• Pharmacology, Toxicology and Pharmaceutics 9.6×
• Nursing 5.2×
• Neuroscience 2.1×
• Immunology and Microbiology 1.7×
• Agricultural and Biological Sciences 1.0×
• Medicine 0.7×

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Metabolism, Aging, Plant Development, Autophagy, Biogenic Amines, Polyamines and Metabolic Disorders.

By volume in 2022–2025: Polyamine Metabolism and Applications, Amino Acid Enzymes and Metabolism, Aldose Reductase and Taurine and Muscle metabolism and nutrition.

1. 1 Polyamine Metabolism and Applications Molecular Biology 1 works
2. 2 Amino Acid Enzymes and Metabolism Biochemistry 1 works
3. 3 Aldose Reductase and Taurine Cell Biology 0 works
4. 4 Muscle metabolism and nutrition Cell Biology 0 works
5. 5 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
6. 6 Protein purification and stability Molecular Biology 0 works
7. 7 Ion Channels and Receptors Sensory Systems 0 works
8. 8 Pharmacological Effects of Natural Compounds Pharmacology 0 works
9. 9 Postharvest Quality and Shelf Life Management Plant Science 0 works
10. 10 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 36% lower than in 2013–2017.

• Chiba University
• Tokyo Dental College
• National Institutes for Quantum Science and Technology
• Chiba University Hospital
• Tokyo University of Information Sciences
• Chiba Cancer Center
• Zen-Noh (Japan)
• The Open University of Japan